Clinical trial

Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer

NCT00619996

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-03-01

PhasePHASE2

Study timeline

Study start (unknown)2007-03-01Date precision: month

Registry last updated2009-02-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Sorafenib (Nexavar)DRUG

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Italian Trial in Medical Oncologylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00619996 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.